about
The role of protease inhibitors in the pathogenesis of HIV-associated lipodystrophy: cellular mechanisms and clinical implicationsWater, electrolytes, and acid-base alterations in human immunodeficiency virus infected patientsFoamy virus vectors for HIV gene therapyNatural Compounds Modulating Mitochondrial FunctionsThe roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunctionHIV-1 infection and first line ART induced differential responses in mitochondria from blood lymphocytes and monocytes: the ANRS EP45 "Aging" studyAgeing and inflammation in patients with HIV infection.Simultaneous analysis of reactive oxygen species and reduced glutathione content in living cells by polychromatic flow cytometry.High-dose clevudine impairs mitochondrial function and glucose-stimulated insulin secretion in INS-1E cells.Zidovudine exposure in HIV-1 infected Tanzanian women increases mitochondrial DNA levels in placenta and umbilical cordsUpregulation of the mitochondrial Lon Protease allows adaptation to acute oxidative stress but dysregulation is associated with chronic stress, disease, and aging.Mitochondrial Lon protease at the crossroads of oxidative stress, ageing and cancer.Mitochondrial toxicity studied with the PBMC of children from the Chinese national pediatric highly active antiretroviral therapy cohort.Obesity and hepatosteatosis in mice with enhanced oxidative DNA damage processing in mitochondria.A modern approach to the treatment of mitochondrial diseaseMetabolic syndrome in relation to cardiorespiratory fitness, active and sedentary behavior in HIV+ Hispanics with and without lipodystrophy.Impact of antiretroviral therapy on lipid metabolism of human immunodeficiency virus-infected patients: Old and new drugs.Viral product trafficking to mitochondria, mechanisms and roles in pathogenesis.HIV-1, reactive oxygen species, and vascular complicationsStrategies to reduce late-stage drug attrition due to mitochondrial toxicity.The effects of Thiazolidinediones on metabolic complications and Lipodystrophy in HIV-infected patientsThe Molecular and Pharmacological Mechanisms of HIV-Related Neuropathic Pain.Long-term exposure to AZT, but not d4T, increases endothelial cell oxidative stress and mitochondrial dysfunction.Identification of mitochondrial genome concatemers in AIDS-associated lymphomas and lymphoid cell lines.Efavirenz: a decade of clinical experience in the treatment of HIV.Endocrine and metabolic abnormalities among HIV-infected patients: a current review.Understanding the etiology and management of HIV-associated peripheral neuropathy.Clinical management of dyslipidaemia associated with combination antiretroviral therapy in HIV-infected patients.Zidovudine impairs adipogenic differentiation through inhibition of clonal expansion.Blepharoptosis and external ophthalmoplegia associated with long-term antiretroviral therapy.
P2860
Q24598812-38D0165F-B41F-4063-9833-DAAB5E4AB01FQ26770753-8D9FD6B4-2372-4F21-82B6-00B67B88BCB1Q26859020-7B654D46-7CF2-4459-A07A-6DD899C5F2B8Q28087261-B1610BC8-9DD2-4FFD-B981-B9AD20BD1441Q28386344-B7EC3F13-B377-412E-88D6-4BC839AE0A4FQ28729025-5A8BF737-AF62-423F-B1C2-8B390CD441B9Q30244296-A558075C-D701-45E0-BA85-F0F8EAC59520Q33518424-DD14038C-A60D-4556-9486-41EF91DBE455Q34121999-8FC81D1A-0251-4737-9378-3C57B2990CDDQ34358732-EE07D5DB-EFE4-4989-AAC4-E9A067D214E0Q34370238-4539AF9D-ED35-4E35-800E-12D212C77021Q34493828-F844FDE9-E146-4176-B663-AC765A181DE4Q34611901-B284047D-DBD3-4A9F-AB40-3C7A93507651Q34805446-98F8BCC4-FD0C-406E-A28E-3FE012C142F9Q35011397-42B11DA2-6E58-4AAD-9212-3711C536FAC0Q35084964-B18C726A-0F8C-469F-8CD4-69A3ECFBDCF8Q35567828-BB8E38D9-4A69-4B94-83AF-78FD75DB88E4Q35619821-DB0157A8-B499-480B-9156-D5F1FBD4E4D8Q36040759-2D64554F-7826-4826-9C94-99FE6ABBA939Q36748508-DCF80F90-9DFA-4087-9362-96B2B087BD62Q36993971-80F9E67D-5691-4A3E-A9C9-89DCF4994C52Q37149019-7EF4FE63-A53C-4277-AB03-2443FE906EF2Q37270571-5D81EA6F-8C30-4207-AC7F-B63016663F6AQ37314450-BC81D840-09CE-4FC2-89A5-484667D5C476Q37383949-2E4068CE-CAE6-4DDD-A463-3B42C5D3483DQ38130907-BB590416-64BC-4595-B7B2-C0783A9787F5Q38223573-339BA1FB-6573-49FA-8C16-A6B1D38AD008Q38723259-D87155BE-3ADC-4D16-88E3-5B7EF4B2DA8FQ41338522-E34A462C-7CDF-4766-9839-1350D05A6A34Q43508252-1BD64B5E-0DCA-4A41-813F-BFA357BA0FE0
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Anti-HIV drugs and the mitochondria.
@ast
Anti-HIV drugs and the mitochondria.
@en
type
label
Anti-HIV drugs and the mitochondria.
@ast
Anti-HIV drugs and the mitochondria.
@en
prefLabel
Anti-HIV drugs and the mitochondria.
@ast
Anti-HIV drugs and the mitochondria.
@en
P1476
Anti-HIV drugs and the mitochondria.
@en
P2093
Paolo Salomoni
P304
P356
10.1016/J.BBABIO.2006.05.001
P407
P577
2006-05-11T00:00:00Z